Department of Pathology, University of Southern California Keck School of Medicine, Los Angeles, California

Similar documents
# Best Practices for IHC Detection and Interpretation of ER, PR, and HER2 Protein Overexpression in Breast Cancer

Brief Formalin Fixation and Rapid Tissue Processing Do Not Affect the Sensitivity of ER Immunohistochemistry of Breast Core Biopsies

Technique and feasibility of a dual staining method for estrogen receptors and AgNORs

Immunohistochemical Expression of Hormone Receptors and The Histological Characteristics of Biochemically Hormone Receptor Negative Breast Cancers

The Effect of Delay in Fixation, Different Fixatives, and Duration of Fixation in Estrogen and Progesterone Receptor Results in Breast Carcinoma

Simultaneous de-waxing and standardisation of antigen retrieval in immunohistochemistry using commercially available equipment

Results you can trust

Layered-IHC (L-IHC): A novel and robust approach to multiplexed immunohistochemistry So many markers and so little tissue

Next-Generation Immunohistochemistry: Multiplex tissue imaging with mass cytometry

Received 04 November 2008; Accepted in revision 09 January 2009; Available online 20 January 2009

Immunohistochemistry in Breast Pathology- Brief Overview of the Technique and Applications in Breast Pathology

Estrogen receptor (ER)

Quality Assurance and Quality Control in the Pathology Dept.

FAQs for UK Pathology Departments

ISPUB.COM. C Choccalingam, L Rao INTRODUCTION ESTROGEN AND PROGESTERONE RECEPTORS

Estrogen receptor (ER)

To enable high quality in the diagnosis of cancer patients,

Immunohistochemistry on Fluid Specimens: Technical Considerations

Immune Cell Phenotyping in Solid Tumors using Quantitative Pathology

Minimum Formalin Fixation Time for Consistent Estrogen Receptor Immunohistochemical Staining of Invasive Breast Carcinoma

What kind of material should we use for ICC in our daily routine. Torill Sauer Department of Pathology, Akershus University Hospital

NordiQC External Quality Assurance in Immunohistochemistry

IMMUNOHISTOCHEMICAL EXPRESSION OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 (TIMP-1) IN INVASIVE BREAST CARCINOMA

Dr. dr. Primariadewi R, SpPA(K)

Single and Multiplex Immunohistochemistry

Abstract. Background. Objective

Value of antimesothelioma HBME 1 in the diagnosis of inflammatory and malignant pleural effusions

Estrogen Receptor, Progesterone Receptor, and Her-2/neu Oncogene Expression in Breast Cancers Among Bangladeshi Women

A Study to Evaluate the Effect of Neoadjuvant Chemotherapy on Hormonal and Her-2 Receptor Status in Carcinoma Breast

Potential Value of Hormone Receptor Assay in Carcinoma In Situ of Breast

Immunotherapy in NSCLC Pathologist role

Validation of a clinical laboratory test means confirmation,

A Rhodes, B Jasani, A J Balaton, K D Miller

Supplemental figure 1. PDGFRα is expressed dominantly by stromal cells surrounding mammary ducts and alveoli. A) IHC staining of PDGFRα in

Estrogen receptor (ER)

WT1, Estrogen Receptor, and Progesterone Receptor as Markers for Breast or Ovarian Primary Sites in Metastatic Adenocarcinoma to Body Fluids

A COMPARISON OF THE EFFECT OF COMMERCIAL

Template for Reporting Results of Biomarker Testing of Specimens From Patients With Carcinoma of the Breast

CANCER. Clinical Validation of Breast Cancer Predictive Markers

Gaining New Insights Through IF Multiplexed Staining and Analysis. Tyna Hope, Ph.D. P.Eng Biomarker Imaging Research Laboratory October 5, 2017

Breast cancer: Antibody selection, protocol optimzation controls and EQA

Comparison of core oestrogen receptor (ER) assay with excised tumour: intratumoral distribution of ER in breast carcinoma

Quality Indicators - Anatomic Pathology- HSC/STC Jul-Sep 2 nd Qtr. Apr-Jun 1 st Qtr

CD15 and CEA expression in thymic epithelial neoplasms

Case Report Aggressive invasive micropapillary salivary duct carcinoma of the parotid gland

Assessment Run B HER-2 IHC. HER-2/chr17 ratio**

HER2 ISH (BRISH or FISH)

Kristen E. Muller, DO, Jonathan D. Marotti, MD, Vincent A. Memoli, MD, Wendy A. Wells, MD, and Laura J. Tafe, MD

Interpretation Manual - Gastric or Gastroesophageal Junction Adenocarcinoma. PD-L1 IHC 22C3 pharmdx is FDA-approved for in vitro diagnostic use

Priti Lal, MD, 1 Paulo A. Salazar, 1 Clifford A. Hudis, MD, 2 Marc Ladanyi, MD, 1 and Beiyun Chen, MD, PhD 1. Abstract

Her-2/neu expression and its correlation with ER status and various clinicopathological parameters

Prostate Immunohistochemistry. Literature Interpretation: Caveats. Must be aware of staining pattern of antibody in the relevant tissue

Product Introduction

Cell Culture. The human thyroid follicular carcinoma cell lines FTC-238, FTC-236 and FTC-

(A) PCR primers (arrows) designed to distinguish wild type (P1+P2), targeted (P1+P2) and excised (P1+P3)14-

Applications of IHC. Determination of the primary site in metastatic tumors of unknown origin

LIST OF ORGANS FOR HISTOPATHOLOGICAL ANALYSIS:!! Neural!!!!!!Respiratory:! Brain : Cerebrum,!!! Lungs and trachea! Olfactory, Cerebellum!!!!Other:!

Tumour markers in breast carcinoma correlate with grade rather than with invasiveness

Assessment Run B HER-2

RESEARCH ARTICLE. Abstract. Introduction

react with these antibodies. Reports from different recent review Crocker and Burnett suggested that

Reporting of Breast Cancer Do s and Don ts

CME/SAM. Guidelines for the Preparation, Release, and Storage of Unstained Archived Diagnostic Tissue Sections for Immunohistochemistry

Expression of androgen receptors in primary breast cancer

RNA preparation from extracted paraffin cores:

High expression of fibroblast activation protein is an adverse prognosticator in gastric cancer.

Melanin Bleaching with Warm Hydrogen Peroxide and Integrated Immunohistochemical Analysis: An Automated Platform

Instant Quality FISH. The name says it all.

KEY WORDS: Breast carcinoma, c-erbb2, Fluorescent. Mod Pathol 2001;14(11):

Proteomic Biomarker Discovery in Breast Cancer

Claudin-4 Expression in Triple Negative Breast Cancer: Correlation with Androgen Receptors and Ki-67 Expression

Table of Contents. 1. Overview. 2. Interpretation Guide. 3. Staining Gallery Cases Negative for CINtec PLUS

COMPUTER-AIDED HER-2/neu EVALUATION IN EXTERNAL QUALITY ASSURANCE (EQA) OF BREAST CANCER SCREENING PROGRAMME

Breast carcinomas expressing basal markers have poor clinical outcome regardless of estrogen receptor status

TrainableImmunohistochemicalHER2/neu Image Analysis. A Multisite Performance Study Using 260 Breast Tissue Specimens

What in the world is Histotechnology? Karen Stiffler, MA, HTL Program Director for Histotechnology

Evaluation of antigen retrieval buffer systems

Product Introduction. Product Codes: HCL029, HCL030 and HCL031. Issue

In some regions of the world, breast cancer mortality beginning to fall due to earlier

Immunostaining was performed on tumor biopsy samples arranged in a tissue-microarray format or on

Quality assurance and quality control in pathology in breast disease centers

Lower 1D5 Sensitivity but Questionable Clinical Implications

Optimal algorithm for HER2 testing

RESEARCH ARTICLE. Wan Faiziah Wan Abdul Rahman 1 *, Mohd Hashairi Fauzi 2, Hasnan Jaafar 1. Abstract. Introduction

Urothelial Carcinoma (UC)

Instant Quality FISH. The name says it all.

Androgen Receptor Expression in Renal Cell Carcinoma: A New Actionable Target?

Epithelial Columnar Breast Lesions: Histopathology and Molecular Markers

Novocastra Liquid Mouse Monoclonal Antibody MyoD1 (Rhabdomyosarcoma Marker)

IHC Polymer. BioGenex Website. Presented for: Presented by: Date: BioGenex Tech Support 2016

Milestones in Her 2 Testing

Assessment Run CK19

Breast Cancer Diversity Various Disease Subtypes Clinical Diversity

Masami SUZUKI, Kiyoka KATSUYAMA, Kenji ADACHI, Yumie OGAWA, Keigo YOROZU, Etsuko FUJII, Yasuyuki MISAWA and Tetsuro SUGIMOTO

Assessment performed on Friday, September 18, 2015, at Vancouver General Hospital

Study of Melanin Bleaching After Immunohistochemistry of Melanin-containing Tissues. Hongwu Shen, MD and Wenqiao Wu, MD

3/22/2017. Disclosure of Relevant Financial Relationships. Ki-67 in Pancreatic Neuroendocrine Neoplasms According to WHO 2017.

Neuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical parameters

Correlation between Immunohistochemical and Biochemical Estrogen Receptors in the Prognosis of Patients with Breast Cancer

Assessment Run B HER2 IHC

Transcription:

Volume 55(2): 105 109, 2007 Journal of Histochemistry & Cytochemistry http://www.jhc.org PERSPECTIVE Standardization of Immunohistochemistry for Formalin-fixed, Paraffin-embedded Tissue Sections Based on the Antigen-retrieval Technique: From Experiments to Hypothesis Shan-Rong Shi, Cheng Liu, and Clive R. Taylor Department of Pathology, University of Southern California Keck School of Medicine, Los Angeles, California SUMMARY From a practical point of view, one of the most difficult issues in the standardization of IHC for FFPE tissue is the adverse influence of formalin upon antigenicity, as well as the great variation in fixation/processing procedures. Based on previous study, an additional study using four markers demonstrated the potential for obtaining equivalent IHC staining among FFPE tissue sections with periods of formalin fixation ranging from 6 hr to 30 days. On this basis, the following hypothesis is proposed. The use of optimized AR protocols permits retrieval of specific proteins (antigens) from FFPE tissues to a defined and reproducible degree (expressed as R%), with reference to the amount of protein present in the original fresh/unfixed tissue. This hypothesis may also be presented mathematically: the protein amount in a fresh cell/tissue, expressed as Pf, produces an IHC signal in fresh tissue of X (Pf). When the identical IHC staining plus AR treatment is applied to a FFPE tissue section, the IHC signal may be represented as X (Pffpe). The degree of retrieval after AR (R%) is calculated as follows: R% 5 X (Pffpe)/ X (Pf) 3 100%. The amount of protein in the FFPE tissue may then be derived as follows: Pffpe 5 Pf 3 R%. In a situation where optimized AR is 100% effective, the IHC signal would then be of equal strength in fresh tissue and FFPE tissue, and Pffpe 5 Pf. Further studies are designed to test the limitations of the proposed hypothesis. (J Histochem Cytochem 55:105 109, 2007) STANDARDIZATION OF IMMUNOHISTOCHEMISTRY (IHC) has been emphasized as a critical issue since 1977 at the First National Cancer Institute Workshop on the standardization of IHC reagents (DeLellis et al. 1979). Subsequently, there have been many attempts to standardize IHC, resulting in numerous articles published worldwide (Taylor and Cote 2005). Nevertheless, standardization remains a great challenge, easier said than done, due in large part to the presence of uncontrollable intrinsic factors such as variable conditions of fixation and tissue processing, which result in levels of antigen preservation that are unknown for thousands of formalin-fixed, paraffin-embedded (FFPE) tissues housed in pathology department archives throughout the world (Leong 2004). Correspondence to: Clive R. Taylor, MD, PhD, Department of Pathology, University of Southern California School of Medicine HMR 204, 2011 Zonal Avenue, Los Angeles, CA 90033. E-mail: taylor@pathfinder.hsc.usc.edu Received for publication August 18, 2006; accepted August 19, 2006 [DOI: 10.1369/jhc.6P7080.2006]. KEY WORDS antigen retrieval standardization of immunohistochemistry formalin-fixed, paraffinembedded tissue A Ftotal test_ approach was advocated in 1992 (Taylor 1992). In essence, the Ftotal test_ embraces all procedures performed to accomplish an IHC stain, from sample collection to writing a final report. From a practical point of view, one of the most difficult issues in the standardization of IHC on FFPE tissues is the adverse influence of formalin, a major uncontrollable intrinsic factor. One proposal seeking to address this difficult issue was the Quicgel method, using a breast cancer cell line embedded in agar gel, processed, and incorporated into the FFPE tissue block side-by-side with the tissue specimen under exactly the same conditions to establish an artificial internal control. It was claimed that the Quicgel method allowed accurate calculation of the amount of protein (estrogen receptor) in the tested sample tissue based on biochemical quantitative analysis (Riera et al. 1999). The Quicgel method, however, has proven not to be practical for routine use due to logistical issues; in addition it is not applicable for retrospective studies on archival tissue. Leong (2004) postulated that internal controls were required for IHC to optimize variable influences due to intrinsic factors. The desired C The Histochemical Society, Inc. 0022-1554/06/$3.30 105

106 Shi, Liu, Taylor internal control should be some tissue component that exists in the same tissue section as the target antigen when tested by IHC. To date, it has proven difficult to identify a quantifiable internal control in FFPE tissue sections for the following reasons: (1) there have been no systematic attempts to identify and quantify non-lesional tissue components that may also be found within the test sample; (2) although ubiquitous candidate proteins do exist, distribution of proteins (antigens) in different tissues may be variable (Pusztaszeri et al. 2006), and their response to processing may be variable; (3) IHC staining methods used must be strictly controlled to yield a reproducible intensity of staining; and (4) computerassisted image analysis will be necessary to measure and compare intensity of the reference standard vs the test antigen. Based on numerous reports that antigen retrieval (AR)-IHC gives excellent results for many of the markers used in diagnostic pathology (Shi et al. 1997), the possibility of improving the standardization of IHC through the use of AR technique has been suggested (Taylor 1994,2006). Furthermore, the use of a Ftest battery_ approach has been advocated to find an optimal protocol of AR-IHC (Shi et al. 1996), based on monitoring the heating condition (temperature and duration of heating) and the ph value of the AR solution, which are the two major factors that influence the effectiveness of AR-IHC. In our experience, a consistent Fmaximal retrieval_ level, showing the strongest intensity of AR-IHC, may be obtained for many antibody/antigen pairings by using this Ftest battery_ approach (Shi et al. 1996). We conducted an experiment using AR-IHC on FFPE tissues fixed in formalin for different periods ranging from 4 hr to 30 days to explore the possibility of obtaining equivalent IHC staining following the maximal retrieval for selected antigen/antibody combinations. In one early study, five antibodies were tested with results that support the notion that it is possible to achieve Fequalized_ maximal immunostaining levels in FFPE tissue sections fixed in formalin for variable times, as long as 1 month (Shi et al. 1998). On this basis, the following hypothesis is proposed. Hypothesis The use of an optimized AR protocol permits retrieval of specific proteins (antigens) from FFPE tissues to a defined and reproducible degree (the retrieved rate of AR, expressed as R%), with reference to the amount of protein present in the original fresh/unfixed tissue. This hypothesis may also be presented mathematically: the protein amount in a fresh cell/tissue, expressed as Pf, produces an IHC signal in fresh tissue of X (Pf). When the identical IHC staining plus AR treatment is applied to a FFPE tissue section, the IHC signal is X (Pffpe). The degree of retrieval after AR (R%) is calculated as follows: R% 5 X (Pffpe)/ X (Pf) 3 100%. The amount of protein in the FFPE tissue may then be derived as follows: Pffpe 5 Pf 3 R%. In a situation where optimized AR is 100% effective, the IHC signal would then be of equal strength in fresh tissue and FFPE tissue, and Pffpe 5 Pf. Based on this hypothesis, it is possible to measure the adverse influence of formalin fixation and tissueembedding processing for certain ubiquitous antigens. Having derived these data experimentally, such antigens may then serve as quantifiable internal reference standards for other test antigens where data are not available with respect to loss or degree of retrieval when compared with fresh frozen tissue. Preliminary Test A preliminary test of this hypothesis was performed using routinely processed FFPE tissue/cell sections of human breast cancer obtained from the Norris Cancer Hospital and Research Institute, Los Angeles, CA and cultured cell pellets of human breast cancer cell line MCF-7 with variable periods of fixation in 10% neutral-buffered formalin (NBF) ranging from 6 hr to 30 days. This study of human archival tissue specimens was exempted under 45 CFR 46.101 (b) and was approved by the Institutional Review Board (IRB #009071) at the University of Southern California. All cell/tissue sections were routinely processed for AR-IHC using 0.05% citraconic anhydride (Sigma Chemical Co.; St Louis, MO), ph 7.5, as the AR solution with a plastic pressure cooker heated in a microwave oven (1100 W, 60 Hz; Sharp Carousel, Bangkok, Thailand) as previously reported (Shi et al. 2000; Namimatsu et al. 2005). To more accurately compare the results of IHC, all staining procedures were performed identically in the same side-by-side run. Four monoclonal antibodies for estrogen receptor (ER, 1:100; NeoMarkers, Fremont, CA), MIB-1 (1:500; Dako, Glostrup, Denmark), cytokeratin (AE-1 cocktail, 1:500; Signet Laboratories, Dedham, MA and CAM 5.2, 1:50; Becton Dickinson, San Jose, CA), and Her-2/neu (1:200; BioGenex Laboratories, San Ramon, CA) were used as the primary antibodies. The Vectastain Elite ABC kit (Vector Laboratories; Burlingame, CA) was used for IHC staining following the manufacturer s instruction. 3,39-DAB was used as chromogen, and hematoxylin was used as counterstain. Positive and negative controls were routinely applied. Evaluation of IHC staining results was conducted by two independent observers by light microscopy. Intensity of positive immunostaining was graded as strong (111), moderate (11), weak (1) ornegative(2). Results All four markers showed positive IHC staining results among FFPE tissue sections fixed for various periods

Standardization of IHC 107 ranging from 6 hr to 30 days, although the immunostaining intensity of 30-day fixed FFPE tissue sections for Her-2/neu and ER was slightly weaker than that obtained in FFPE tissue sections fixed for shorter periods. Both intensity and percentage of positively stained cells in all FFPE tissue sections achieved a strong (111) level (Figure 1). This preliminary test supports the potential feasibility of standardization of IHC staining results in tissues undergoing variable periods of formalin fixation, as indicated by our previous study (Shi et al. 1998). Further Experiments Designed for Testing Hypothesis To examine this hypothesis, further studies are necessary, beginning with the use of a well-defined cell/ tissue model system in which the amount of selected antigen can be measured accurately on a cell-to-cell basis in fresh and FFPE specimens. The cell/tissue model system is established based on quantitatively comparable cell lines that are processed in fresh frozen and FFPE cell/tissue blocks under variable conditions, including the period of formalin fixation, delayed times of fixation, and varying storage conditions, as well as other technical issues such as thickness of each tissue section. The experiment is designed to simulate fixation and processing schedules in general use in histopathology laboratories. By using this model system, serial experiments may be carried out to examine the hypothesis based upon a multi-dimensional study such as depicted in the Fvector-gram_ (Figure 2). IHC must be performed in a side-by-side fashion for accurate comparison of immunostaining intensity and evaluated by appropriate standard positive controls. It is also necessary to evaluate the intensity of IHC based on both manual and computer-assisted image analysis. Use of a tissue microarray method is proposed to simplify Figure 1 Comparison of immunohistochemical staining results among variable periods, 6 hr (h) to 30 days (d), of formalin-fixed, paraffinembedded human breast cancer tissue (A N) and cell line MCF-7 sections (O B1). All four markers, estrogen receptor (ER) (A G), CK (cytokeratin cocktail, H N), Her-2/neu (O U), and MIB-1 (V B1), showed comparable positive immunostaining results at 111 level after antigen retrieval. Bar 5 50 mm.

108 Shi, Liu, Taylor Figure 2 Diagram depicts the furtherdesigned studies to test our hypothesis with respect to standardization of immunohistochemistry based on the antigen-retrieval technique exemplified in a multiple direction to draw a conclusion. (A) Periods of formalin fixation. (B) Variable delay of fixation. (C) Storage of FFPE tissue blocks or sections. (D) Variable thickness of FFPE tissue sections. (E) Other variable conditions of processing FFPE tissue blocks. The stereoscopic frame of a cube represents the reliable limitation of quantitative IHC demonstrated by serial studies as recommended in the text. these tests using either a series of algorithms called AQUA technology for quantitative assessment (Cregger et al. 2006) or comparative spectral imaging in double- or triple-stained slides. A selected antibody panel including cytoplasmic, nuclear, and surface markers will be tested to confirm results. Accurate biochemical quantification of proteins in cell/tissue model will be required for validation of IHC findings. Finally, to test the accuracy of protein quantification in FFPE tissue sections by this approach, it will be essential to perform a parallel study on selected human tissue sections with known amounts of certain proteins (e.g., ER) in a double-blind fashion. The initial research design using the cell/tissue model is presented to examine the limitations of this hypothesis based on correlated accurate quantitative biochemical measurements and IHC staining results. Publications Relevant to the Hypothesis In addition to the preliminary studies described here, there is a body of literature that supports the notion that effective optimal AR may be a useful approach to Fneutralizing_ the adverse and variable effects of fixation. Boenisch (2005) documented a recent IHC study using human tonsil tissue fixed in 10% NBF for 12 hr and 1, 2, 4, and 8 days to determine whether AR could be applied to Fequalize_ variable immunostaining results resulting from inconsistent formalin fixation. Among 30 antibodies tested in his experiment, 26 showed consistent optimal staining by using one single AR protocol (0.01 M citrate buffer, ph 6.0, with heating at 97C for 20 to 60 min). Boenisch concluded that Application of a given method for heat retrieval can compensate for variable formalin-induced damages resulting from inconsistencies in the length of formalin fixation and thus equally restore the immunoreactivities on a wider scale of antigens. Other articles demonstrate consistent restoration of immunoreactivity (AR rate 5 100%) for many antigens (proteins), exemplified by ER, progesterone receptor (PR), HER-2/neu, Ki-67 (MIB-1), etc. for FFPE tissues, indicating high concordance between IHC and positive biochemical results (MacGrogan et al. 1996; Pertschuk and Axiotis 2000). More than a dozen articles have demonstrated comparable IHC staining results between frozen and FFPE tissue sections following AR. For example, Von Boguslawsky (1994) performed IHC detection of PR for 25 paired frozen and FFPE tissue sections of breast cancer to compare the percentage of positively stained nuclei between frozen and FFPE tissue sections and demonstrated that with the AR treatment, 84% (21/25) of FFPE tissue sections showed identical positive nuclear staining to that obtained in frozen tissue

Standardization of IHC 109 sections. Among the remaining four cases (4/25), compared to the frozen tissue sections only one case showed a lower percentage of positive cells in the FFPE tissue section. Higher percentages of positive staining were found in the other three cases for FFPE tissue sections. Reliable Finter-laboratory_ IHC staining for Her-2/ neu, ER, etc. also can be achieved based on optimal AR- IHC protocols and stringent quality control using standard reference materials (Jacobs et al. 2000; Rhodes et al. 2000,2002). In conclusion, broad-based experimental data from multiple investigators support the notion that carefully performed AR-IHC has the potential to greatly improve the reliability of IHC staining. In addition, using this approach it may be possible to identify certain ubiquitous antigens that show a consistent degree of restoration of antigenicity following optimized AR. Such antigens, when accurately quantified by controlled experiments, may serve as the basis for developing a panel of Fquantifiable internal reference standards_ for IHC. Further studies are required, but the initial findings are encouragingforapositiveandusefuloutcome. Acknowledgments This study was supported by National Institutes of Health, Grant 1 R33 CA-103455-01. We thank Henry Lin, PhD student at the Department of Pathology, University of Southern California, for his kind help in preparing figures. Literature Cited Boenisch T (2005) Effect of heat-induced antigen retrieval following inconsistent formalin fixation. Appl Immunohistochem Mol Morphol 13:283 286 Cregger M, Berger AJ, Rimm DL (2006) Immunohistochemistry and quantitative analysis of protein expression. Arch Pathol Lab Med 130:1026 1030 DeLellis RA, Sternberger LA, Mann RB, Banks PM, Nakane PK (1979) Immunoperoxidase technics in diagnostic pathology. Report of a workshop sponsored by the National Cancer Institute. Am J Clin Pathol 71:483 488 Jacobs TW, Gown AM, Yaziji H, Barnes MJ, Schnitt SJ (2000) HER- 2/neu protein expression in breast cancer evaluated by immunohistochemistry. A study of interlaboratory agreement. Am J Clin Pathol 113:251 258 Leong AS-Y (2004) Quantitation in immunohistology: fact or fiction? A discussion of variables that influence results. Appl Immunohistochem Mol Morphol 12:1 7 MacGrogan G, Soubeyran I, De Mascarel I, Wafflart J, Bonichon F, Durand M, Avril A, et al. (1996) Immunohistochemical detection of progesterone receptors in breast invasive ductal carcinomas. Appl Immunohistochem 4:219 227 Namimatsu S, Ghazizadeh M, Sugisaki Y (2005) Reversing the effects of formalin fixation with citraconic anhydride and heat: a universal antigen retrieval method. J Histochem Cytochem 53:3 11 Pertschuk LP, Axiotis CA (2000) Antigen retrieval for detection of steroid hormone receptors. In Shi S-R, Gu J, Taylor CR, eds. Antigen Retrieval Techniques: Immunohistochemistry and Molecular Morphology. Natick, MA, Eaton Publishing, 153 164 Pusztaszeri M, Seelentag W, Bosman FT (2006) Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem 54:385 395 Rhodes A, Jasani B, Anderson E, Dodson AR, Balaton AJ (2002) Evaluation of HER-2/neu immunohistochemical assay sensitivity and scoring on formalin-fixed and paraffin-processed cell lines and breast tumors: a comparative study involving results from laboratories in 21 countries. Am J Clin Pathol 118:408 417 Rhodes A, Jasani B, Balaton AJ, Miller KD (2000) Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on in house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries. J Clin Pathol 53:292 301 Riera J, Simpson JF, Tamayo R, Battifora H (1999) Use of cultured cells as a control for quantitative immunocytochemical analysis of estrogen receptor in breast cancer. The Quicgel method. Am J Clin Pathol 111:329 335 Shi S-R, Cote RJ, Chaiwun B, Young LL, Shi Y, Hawes D, Chen T, et al. (1998) Standardization of immunohistochemistry based on antigen retrieval technique for routine formalin-fixed tissue sections. Appl Immunohistochem 6:89 96 Shi S-R, Cote RJ, Shi Y, Taylor CR (2000) Antigen retrieval technique. In Shi S-R, Gu J, Taylor CR, eds. Antigen Retrieval Techniques: Immunohistochemistry and Molecular Morphology. Natick, MA, Eaton Publishing, 311 333 Shi S-R, Cote RJ, Taylor CR (1997) Antigen retrieval immunohistochemistry: past, present, and future. J Histochem Cytochem 45: 327 343 Shi SR, Cote RJ, Yang C, Chen C, Xu HJ, Benedict WF, Taylor CR (1996) Development of an optimal protocol for antigen retrieval: a Ftest battery_ approach exemplified with reference to the staining of retinoblastoma protein (prb) in formalin-fixed paraffin sections. J Pathol 179:347 352 Taylor CR (1992) Quality assurance and standardization in immunohistochemistry. A proposal for the annual meeting of the Biological Stain Commission. Biotech Histochem 67:110 117 Taylor CR (1994) An exaltation of experts: concerted efforts in the standardization of immunohistochemistry. Hum Pathol 25: 2 11 Taylor CR (2006) Standardization in immunohistochemistry: the role of antigen retrieval in molecular morphology. Biotech Histochem 81:3 12 Taylor CR, Cote RJ (2005) Immunomicroscopy. A Diagnostic Tool for the Surgical Pathologist. 3rd ed. Philadelphia, Elsevier Saunders, 1 45 Von Boguslawsky K (1994) Immunohistochemical detection of progesterone receptors in paraffin sections. APMIS 102:641 646